Tissue Regeneration Systems, Inc.

Kirkland, WA 98033

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.17MM
First Award Date 08/13/09
Most Recent Award Date 09/01/12

Key Personnel

Last Name Name Awards Contact
Jongpaiboonkit Leenaporn Jongpaiboonkit 4
Migneco Francesco Migneco 2

4 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/01/12 - 08/31/13

DESCRIPTION (provided by applicant): Large mandibular segmental defects resulting from tumor resection, trauma, and congenital anomalies remain one of the most difficult clinical challenges in CMF reconstruction. Autologous tissue grafts and synthetic materials are the current clinical gold standard but suffer from significant drawbacks that mak...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/02/11 - 08/31/12

DESCRIPTION (provided by applicant): Large mandibular segmental defects resulting from tumor resection, trauma, and congenital anomalies remain one of the most difficult clinical challenges in CMF reconstruction. Autologous tissue grafts and synthetic materials are the current clinical gold standard but suffer from significant drawbacks that mak...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 06/01/11 - 06/30/12

DESCRIPTION (provided by applicant): The purpose of the proposal is to develop medical device coatings that bind and release therapeutic proteins, particularly growth factors. Specifically, we propose to systematically optimize and control growth factor binding and release using protocols that can be translated to the operating room. Bone fractu...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/13/09 - 07/31/10

DESCRIPTION (provided by applicant): Craniomaxillafacial (CMF) reconstruction remains a significant challenge due to the complex geometry and the need to restore both esthetics and function, especially for large mandibular segmental defects resulting from tumor resection, trauma or congenital defects. The current clinical gold standard, vascula...